These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25614528)

  • 1. Implementing extended-infusion cefepime as standard of care in a children's hospital: a prospective descriptive study.
    Nichols KR; Karmire LC; Cox EG; Kays MB; Knoderer CA
    Ann Pharmacother; 2015 Apr; 49(4):419-26. PubMed ID: 25614528
    [TBL] [Abstract][Full Text] [Related]  

  • 2. System-wide implementation of the use of an extended-infusion piperacillin/tazobactam dosing strategy: feasibility of utilization from a children's hospital perspective.
    Nichols KR; Knoderer CA; Cox EG; Kays MB
    Clin Ther; 2012 Jun; 34(6):1459-65. PubMed ID: 22657253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended infusion compared to standard infusion cefepime as empiric treatment of febrile neutropenia.
    Wrenn RH; Cluck D; Kennedy L; Ohl C; Williamson JC
    J Oncol Pharm Pract; 2018 Apr; 24(3):170-175. PubMed ID: 28077047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN; Micek ST; Reichley RM; Ritchie DJ
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of urinary tract infections among febrile young children with daily intravenous antibiotic therapy at a day treatment center.
    Gauthier M; Chevalier I; Sterescu A; Bergeron S; Brunet S; Taddeo D
    Pediatrics; 2004 Oct; 114(4):e469-76. PubMed ID: 15466073
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Extended-infusion cefepime reduces mortality in patients with Pseudomonas aeruginosa infections.
    Bauer KA; West JE; O'Brien JM; Goff DA
    Antimicrob Agents Chemother; 2013 Jul; 57(7):2907-12. PubMed ID: 23571547
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged infusion antibiotics for suspected gram-negative infections in the ICU: a before-after study.
    Arnold HM; Hollands JM; Skrupky LP; Smith JR; Juang PH; Hampton NB; McCormick S; Reichley RM; Hoban A; Hoffmann J; Micek ST; Kollef MH
    Ann Pharmacother; 2013 Feb; 47(2):170-80. PubMed ID: 23341160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluating outcomes of alternative dosing strategies for cefepime: a qualitative systematic review.
    Burgess SV; Mabasa VH; Chow I; Ensom MH
    Ann Pharmacother; 2015 Mar; 49(3):311-22. PubMed ID: 25575975
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rates and appropriateness of antimicrobial prescribing at an academic children's hospital, 2007-2010.
    Levy ER; Swami S; Dubois SG; Wendt R; Banerjee R
    Infect Control Hosp Epidemiol; 2012 Apr; 33(4):346-53. PubMed ID: 22418629
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug use evaluation of cefepime in the first affiliated hospital of Bengbu medical college: a retrospective and prospective analysis.
    Shi Q; Ding F; Sang R; Liu Y; Yuan H; Yu M
    BMC Infect Dis; 2013 Apr; 13():160. PubMed ID: 23551828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Population pharmacokinetics of cefepime in the neonate.
    Capparelli E; Hochwald C; Rasmussen M; Parham A; Bradley J; Moya F
    Antimicrob Agents Chemother; 2005 Jul; 49(7):2760-6. PubMed ID: 15980347
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monotherapy with piperacillin/tazobactam versus cefepime as empirical therapy for febrile neutropenia in pediatric cancer patients: a randomized comparison.
    Corapcioglu F; Sarper N; Zengin E
    Pediatr Hematol Oncol; 2006; 23(3):177-86. PubMed ID: 16517534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population pharmacokinetics of cefepime in neonates with severe nosocomial infections.
    Lima-Rogel V; Medina-Rojas EL; Del Carmen Milán-Segovia R; Noyola DE; Nieto-Aguirre K; López-Delarosa A; Romano-Moreno S
    J Clin Pharm Ther; 2008 Jun; 33(3):295-306. PubMed ID: 18452417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic rationale for cefepime dosing regimens in intensive care units.
    Roos JF; Bulitta J; Lipman J; Kirkpatrick CM
    J Antimicrob Chemother; 2006 Nov; 58(5):987-93. PubMed ID: 16943209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cefepime neurotoxicity in the intensive care unit: a cause of severe, underappreciated encephalopathy.
    Fugate JE; Kalimullah EA; Hocker SE; Clark SL; Wijdicks EF; Rabinstein AA
    Crit Care; 2013 Nov; 17(6):R264. PubMed ID: 24200036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Review of the pharmacokinetics of cefepime in children.
    Blumer JL; Reed MD; Knupp C
    Pediatr Infect Dis J; 2001 Mar; 20(3):337-42. PubMed ID: 11303847
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of Intravenous Vancomycin and Cefepime in Preventing Endophthalmitis After Open Globe Injury.
    Huang JM; Pansick AD; Blomquist PH
    J Ocul Pharmacol Ther; 2016 Sep; 32(7):437-41. PubMed ID: 27414817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steady-state plasma and intrapulmonary concentrations of cefepime administered in continuous infusion in critically ill patients with severe nosocomial pneumonia.
    Boselli E; Breilh D; Duflo F; Saux MC; Debon R; Chassard D; Allaouchiche B
    Crit Care Med; 2003 Aug; 31(8):2102-6. PubMed ID: 12973166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug utilization study of two generic antibiotics in a tertiary hospital in Bogotá.
    López JJ; Cortázar Y; Acosta Á; Vargas-Peláez CM; Rossi F
    Biomedica; 2018 Sep; 38(3):398-406. PubMed ID: 30335245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous and extended infusions of β-lactam antibiotics in the pediatric population.
    Walker MC; Lam WM; Manasco KB
    Ann Pharmacother; 2012 Nov; 46(11):1537-46. PubMed ID: 23115223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.